ニュース

ロイター7年
U.S. FDA Expands Approval Of Imfinzi To Reduce The Risk Of Non-Small Cell Lung Cancer ...
* FDA - GRANTED THE APPROVAL OF IMFINZI TO ASTRAZENECA‍ Source text: Further company coverage ...